Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Akerblom

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Epidemiology and Infection|April 7, 1998
Identification of two antigenically and genetically distinct lineages of H3N8 equine influenza virus in SwedenL Oxburgh, L Akerblom, T Fridberger, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challengeA Osterhaus, P de Vries, B Morein, et al.
Biotechnology and Applied Biochemistry|May 21, 1999
Colorimetric capture assay for human-immunodeficiency-virus-I reverse transcriptase activityA S Rytting, L Akerblom, J S Gronowitz, et al.
Scandinavian Journal of Immunology|October 1, 1992
Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical formsM Bergström-Mollaoglu, K Lövgren, L Akerblom, et al.
Vaccine|February 1, 1995
Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensisI Golovliov, M Ericsson, L Akerblom, et al.
Vaccine|March 1, 1996
Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systemsS Sjölander, J E Hansen, K Lövgren-Bengtsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1981
Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cellsL Akerblom, A Ehrenberg, A Gräslund, et al.
Journal of Virology|February 1, 1990
A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralizationP A Broliden, K Ljunggren, J Hinkula, et al.
Clinical and Experimental Immunology|August 26, 1998
The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responsesK F Hu, M Elvander, M Merza, et al.
Archives of Virology|January 1, 1995
The HIV-1 V3 domain on field isolates: participation in generation of escape virus in vivo and accessibility to neutralizing antibodiesM Arendrup, L Akerblom, P M Heegaard, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Epidemiology and Infection|April 7, 1998
Identification of two antigenically and genetically distinct lineages of H3N8 equine influenza virus in SwedenL Oxburgh, L Akerblom, T Fridberger, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challengeA Osterhaus, P de Vries, B Morein, et al.
Biotechnology and Applied Biochemistry|May 21, 1999
Colorimetric capture assay for human-immunodeficiency-virus-I reverse transcriptase activityA S Rytting, L Akerblom, J S Gronowitz, et al.
Scandinavian Journal of Immunology|October 1, 1992
Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical formsM Bergström-Mollaoglu, K Lövgren, L Akerblom, et al.
Vaccine|February 1, 1995
Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensisI Golovliov, M Ericsson, L Akerblom, et al.
Vaccine|March 1, 1996
Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systemsS Sjölander, J E Hansen, K Lövgren-Bengtsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1981
Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cellsL Akerblom, A Ehrenberg, A Gräslund, et al.
Journal of Virology|February 1, 1990
A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralizationP A Broliden, K Ljunggren, J Hinkula, et al.
Clinical and Experimental Immunology|August 26, 1998
The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responsesK F Hu, M Elvander, M Merza, et al.
Archives of Virology|January 1, 1995
The HIV-1 V3 domain on field isolates: participation in generation of escape virus in vivo and accessibility to neutralizing antibodiesM Arendrup, L Akerblom, P M Heegaard, et al.
Pageof 5